If you include the R&D staff costs it’s about the same as the December quarter.
Advertising and marketing set to double .... which is good.
You’ve got to spend money to make money.
Looks like 2019 is set for some good growth as we hit new markets.
- Forums
- ASX - By Stock
- Ann: MedAdvisor Quarterly Report & Appendix 4C
MDR
medadvisor limited
Add to My Watchlist
5.00%
!
8.4¢

If you include the R&D staff costs it’s about the same as the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.4¢ |
Change
0.004(5.00%) |
Mkt cap ! $52.48M |
Open | High | Low | Value | Volume |
8.0¢ | 8.4¢ | 7.8¢ | $38.67K | 482.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 121019 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 73921 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 121019 | 0.081 |
3 | 51771 | 0.078 |
1 | 120000 | 0.077 |
4 | 272644 | 0.076 |
2 | 59833 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 73921 | 1 |
0.088 | 1944 | 1 |
0.090 | 40000 | 1 |
0.091 | 100000 | 1 |
0.095 | 10588 | 1 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online